Skip to content

Search Results

No Matching Results

    Recently Viewed

      Listening...

      HomeJ&J Innovative Medicine

      J&J Innovative Medicine

      Microbiome researcher Jeffrey Gordon receives the 2022 Dr. Paul Janssen Award for biomedical research

      Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health. The winner for 2022 is internationally known for his research on the human gut microbiome and its impact on health and disease.

      By the numbers: Helping to reduce disparities in cancer care

      For World Health Day, learn how Johnson & Johnson’s commitment to Diversity, Equity and Inclusion is helping to deliver transformational cancer treatments and solutions that reach the patients who need them most.

      Johnson & Johnson named a 2023 Fortune World’s Most Admired Company and ranked #1 on the Pharmaceutical Industry list.

      A commitment to social responsibility and innovation are just two of the attributes that helped the company land a spot on the prestigious list once again.

      What you need to know about Johnson & Johnson’s 2022 fourth-quarter and full-year earnings report

      Check out this infographic breakdown of the company’s fourth-quarter and annual performance, with highlights from its Pharmaceutical, MedTech and Consumer Health businesses.

      How advances in HIV treatment could help young people living with HIV

      We spoke to a scientist behind a treatment for the disease that was recently FDA-approved for adolescents ages 12 to 18 to learn how it could give them new hope.

      What happens when antibiotics stop working?

      More and more, many previously effective medications are no longer able to fight off the germs that are making us sick, leading to millions of deaths each year. For World Antimicrobial Awareness Week, learn what Johnson & Johnson is doing to combat this health threat around the world.

      What are autoantibodies?

      More than 200 million people worldwide are living with an autoantibody disease, which occurs when the body attacks its own cells, tissues and proteins.

      What you need to know about Johnson & Johnson’s 2022 third-quarter earnings

      Check out this infographic breakdown of the company’s third-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.

      How Johnson & Johnson is supporting mental healthcare in the Hispanic and Latino communities

      From cultural stigma to language barriers, getting necessary treatment can be challenging for these groups. For Mental Health Awareness Month, learn more about what the company is doing to help people surmount unique obstacles to get the resources they need.

      Johnson & Johnson debuts a groundbreaking R&D facility in the San Francisco Bay Area

      Take a look inside the new cutting-edge hub for medical innovation where company scientists and other researchers will collaborate to help find solutions for some of the world’s toughest health challenges.